Keratinocyte growth factor

DRUG3 trials

Sponsors

University Hospital Southampton NHS Foundation Trust, Montefiore Medical Center, University of Arizona

Conditions

Allogeneic Hematopoietic Stem Cell TransplantationAlopeciaAlopecia DrugsBronchial AsthmaChemotherapy-Induced ChangeHair LossNeuroepithelial TumorSolid Tumor

Early Phase 1

A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors

TerminatedNCT02653196

Montefiore Medical CenterAllogeneic Hematopoietic Stem Cell Transplantation, Neuroepithelial Tumor, Solid Tumor

Start: 2015-09-30End: 2017-08-31Updated: 2017-08-17

Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia

CompletedNCT04554732

University of ArizonaAlopecia, Alopecia Drugs, Chemotherapy-Induced Change +1

Start: 2020-04-27End: 2022-06-24Updated: 2022-12-16

Phase 2

A Study to Assess Safety and Efficacy of a Novel Treatment, Keratinocyte Growth Factor (KGF), in Asthmatic Patients

CompletedNCT01386151

University Hospital Southampton NHS Foundation TrustBronchial Asthma

Start: 2009-08-31End: 2011-07-31Updated: 2016-10-13

Related Papers

Investigating keratinocyte growth factor hair serum for the prevention of chemotherapy-induced alopecia.

Journal of Clinical Oncology2022-09-30